Home
Anatara Lifesciences Ltd
ASX Code
ANR
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://anataralifesciences.com/investors/
Website
https://anataralifesciences.com/
About
Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.
Introducing Anatara’s technology Bromelain is a mixture of proteases extracted from pineapple stems. Specific proteases within Bromelain have anti-attachment, anti-secretory and anti-inflammatory activity. Collectively, these proteases provide a broad spectrum of activity as they not only prevent the diarrhoea-causing organism from attaching to the small intestine in the first place, but they also block inflammation and the secretory action of toxins, the underlying cause of diarrhoea. Anatara is developing proprietary formulations of bromelain for the prevention and treatment of gastrointestinal diseases in animals and humans.